American International Group, Inc. Bluebird Bio, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.91 - $1.75 $37,471 - $72,059	41,177 Added 77.41%	94,371 $120,000
Q4 2023 Feb 13, 2024	SELL	$1.32 - $4.83 $282 - $1,033	-214 Reduced 0.4%	53,194 $73,000
Q3 2023 Nov 13, 2023	BUY	$3.02 - $4.05 $5,731 - $7,686	1,898 Added 3.68%	53,408 $162,000
Q2 2023 Aug 04, 2023	BUY	$2.79 - $5.03 $4,921 - $8,872	1,764 Added 3.55%	51,510 $169,000
Q1 2023 May 12, 2023	BUY	$3.14 - $8.22 $32,882 - $86,079	10,472 Added 26.66%	49,746 $158,000
Q4 2022 Feb 10, 2023	BUY	$5.77 - $8.49 $15,053 - $22,150	2,609 Added 7.12%	39,274 $271,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $11,913 - $23,478	3,177 Added 9.49%	36,665 $232,000
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $138 - $245	-47 Reduced 0.14%	33,488 $139,000
Q1 2022 May 13, 2022	SELL	$4.07 - $10.6 $9,605 - $25,016	-2,360 Reduced 6.57%	33,535 $163,000
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $9,623 - $17,516	-1,074 Reduced 2.91%	35,895 $359,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $9,868 - $18,438	-878 Reduced 2.32%	36,969 $706,000
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $662,897 - $811,719	36,746 Added 3337.51%	37,847 $1.21 Million
Q1 2021 May 07, 2021	SELL	$16.59 - $33.89 $1,924 - $3,931	-116 Reduced 9.53%	1,101 $33,000
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $907 - $1,251	-33 Reduced 2.64%	1,217 $53,000
Q3 2020 Nov 04, 2020	SELL	$34.44 - $43.75 $275 - $350	-8 Reduced 0.64%	1,250 $67,000
Q2 2020 Aug 12, 2020	BUY	$27.12 - $45.97 $9,790 - $16,595	361 Added 40.25%	1,258 $77,000
Q1 2020 May 04, 2020	BUY	$26.16 - $63.5 $889 - $2,159	34 Added 3.94%	897 $41,000
Q4 2019 Feb 05, 2020	SELL	$46.96 - $61.67 $1,361 - $1,788	-29 Reduced 3.25%	863 $76,000
Q2 2019 Aug 13, 2019	SELL	$75.84 - $105.21 $19,642 - $27,249	-259 Reduced 22.5%	892 $113,000
Q1 2019 May 06, 2019	SELL	$64.44 - $104.11 $2,577 - $4,164	-40 Reduced 3.36%	1,151 $181,000
Q3 2018 Nov 09, 2018	BUY	$88.86 - $117.49 $5,953 - $7,871	67 Added 5.96%	1,191 $174,000
Q2 2018 Aug 08, 2018	SELL	$99.64 - $127.59 $3.01 Million - $3.85 Million	-30,161 Reduced 96.41%	1,124 $176,000
Q1 2018 May 07, 2018	SELL	$105.8 - $150.94 $178,061 - $254,032	-1,683 Reduced 5.1%	31,285 $5.34 Million
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $235,056 - $378,115	2,893 Added 9.62%	32,968 $5.87 Million
Q3 2017 Nov 09, 2017	BUY	$57.74 - $91.42 $1.74 Million - $2.75 Million	30,075	30,075 $4.13 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.88 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.73 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.73 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.42 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account